Salix Wins Jury Verdict In Breach Suit Over Napo Drug

By Kurt Orzeck (February 25, 2014, 5:56 PM EST) -- A New York state jury decided on Tuesday that Salix Pharmaceuticals Inc. met its contractual obligations in commercializing anti-diarrheal drug crofelemer and thus didn't breach a license agreement with Napo Pharmaceuticals Inc., as the partner's suit alleged, according to the defendant....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!